Thyroid

Thyroid RFA (Radiofrequency Ablation) is a minimally invasive medical procedure used to treat benign thyroid nodules by delivering controlled radiofrequency energy directly into the nodule tissue. The procedure aims to alleviate symptoms such as compression of adjacent structures, difficulty swallowing, or cosmetic concerns, while preserving the function of the surrounding healthy thyroid tissue.

During the procedure, a thin needle electrode is inserted directly into the thyroid nodule under ultrasound guidance. Radiofrequency energy is then applied selectively to different areas within the nodule. This energy generates heat, which thermally ablates (destroys) the nodule, causing it to degenerate and shrink gradually over several months.

It is performed as an outpatient procedure under local anaesthesia, leading to shorter recovery times, no scarring, sustained reduction in nodule volume, low complication rates, and improved post-procedure quality of life. These advantages position RFA as a favourable alternative to surgery for managing benign thyroid nodules globally. Importantly, RFA is designed to preserve surrounding healthy thyroid tissue, minimising damage and allowing the thyroid to function normally without the need for lifelong medication.